Ibis Biosciences has developed RNA-based technology for the identification of infectious microorganisms.
History:
Ibis Technologies, a division of Isis Pharmaceuticals, used to be called Ibis Therapeutics when they were focusing on developing RNA-binding small molecule drugs. They have since changed their name to Ibis Biosciences.
